Curetis Retains H.C. Wainwright & Co. as Strategic Advisor Investment bank supports Curetis in assessment of all strategic and tactical financing options Publication ofH1-2019 financials postponed to September 18, 2019 Key financials show EUR 7.8 million cash as of June 30, 2019 and significantly reduced cash burn inH1-2019 Elements of this announcement contain or may contain inside information within the meaning of Article 7(1) of the Market Abuse Regulation. Amsterdam, the Netherlands, and Holzgerlingen, Germany, August 12, 2019, 08:00 am CET- Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a developer of next-level molecular diagnostic...
|
